To investigate the molecular mechanisms underlying the action of CMTM6 in trastuzumab resistance in BC tissues, the relationship between ERBB2 and CMTM6 expression in TCGA-BRCA datasets was analyzed by GSEA enrichment analysis. Here, CMTM6 is linked to breast cancer.